News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Sanofi-Aventis (France) Gets Clearance To Market Plavix In Japan
January 25, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PARIS (Reuters) - Sanofi-Aventis (SASY.PA: Quote, Profile, Research), the world's third-largest drugmaker, said on Tuesday it had won clearance from Japanese authorities to market its blood-thinner treatment product Plavix in Japan.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Regulatory
Europe
Bristol Myers Squibb Company
Sanofi
MORE ON THIS TOPIC
Layoffs
Agios axes 100-plus R&D roles while awaiting FDA decision
November 6, 2026
·
2 min read
·
Gabrielle Masson
FDA
Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November
November 6, 2026
·
4 min read
·
Tristan Manalac
Manufacturing
Merck, Moderna serve 99% of trial patients with mRNA vaccine as personalized shots near market
November 6, 2026
·
2 min read
·
Annalee Armstrong
Drug Development
Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma
November 5, 2026
·
3 min read
·
Heather McKenzie